Clinical Trials Browser

Fibrolamellar hepatocellular carcinoma, Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Melanoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma

NCT04126200 2025-11-06

DREAMM5

Phase 2 Active not recruiting

208 enrolled

Plasma cell

Multiple Myeloma

NCT02817633 2025-10-28

A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

Phase 1 Active not recruiting

463 enrolled

DermatologicGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Colorectal Neoplasms

NCT04446351 2025-10-27

Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors

Phase 1 Active not recruiting

107 enrolled

Tumor-Agnostic

Neoplasms

NCT04655976 2025-09-26

COSTAR Lung

Phase 3 Active not recruiting

758 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06472076 2025-09-10

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

Phase 3 Active not recruiting

88 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03981796 2025-09-03

RUBY

Phase 3 Active not recruiting

785 enrolled 2 FDA

Neoplasms, Recurrence

NCT06317311 2025-07-25

RUBY-J

Phase 2 Active not recruiting

41 enrolled

Gynecologic

Carcinoma, Endometrial Neoplasms

NCT05060432 2024-06-21

TIG-006

Phase 1/2 Active not recruiting

153 enrolled

DermatologicHead & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Melanoma

Clinical Trials

PULMO-01

A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202

A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors

A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer

AZUR-1

FIRST

China AZUR-1

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

DREAMM5

A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors

COSTAR Lung

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

RUBY

RUBY-J

TIG-006